Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email
temporary image

Wanping Xu, Ph.D.

  • Program Director
240-858-3957 |

Dr. Wanping Xu manages a portfolio of grants  focusing on cancer cachexia biological pathways, cancer signaling pathways, and cellular chaperones.

Dr. Xu is interested in new technologies and approaches that have enabled scientists to understand the dynamic and translocation processes in cell signaling.

 

Background

Prior to DCB, he was a staff scientist at the NCI Center for Cancer Research (CCR) where he studied heat shock protein 90 (Hsp90). 

 

Education 

  • Ph.D, Molecular and Cellular Biology, University of Maryland- Baltimore  


 

  • Updated:
Email